Get started
Author

Gail Duncan

Observed names: G. Duncan, G.G. Duncan
Observed institution: Fox Chase Cancer Center
OpenAlex ID: A5086423725
Neoadjuvant dose-dense gemcitabine and cisplatin (DDGC) in patients (pts) with muscle-invasive bladder cancer (MIBC): Final results of a multicenter phase II study.
2014 · Elizabeth R. Plimack, Jean H. Hoffman-Censits, et al. · Journal of Clinical Oncology · 22
Multi-institutional phase I study of low-dose ultra-fractionated radiotherapy as a chemosensitizer for gemcitabine and erlotinib in patients with locally advanced or limited metastatic pancreatic cancer
2014 · Andre Konski, Joshua E. Meyer, et al. · Radiotherapy and Oncology · 14
Neoadjuvant accelerated MVAC (AMVAC) in patients with muscle invasive bladder cancer: Results of a multicenter phase II study.
2012 · Elizabeth R. Plimack, Jean H. Hoffman-Censits, et al. · Journal of Clinical Oncology · 7
517 oral QOL / OUTCOMES OF AN INTERNATIONAL PHASE 3 TRIAL OF INTERMITTENT V CONTINUOUS HORMONE THERAPY FOR RELAPSED PROSTATE CA
2011 · G.G. Duncan, C. O'Callaghan, et al. · Radiotherapy and Oncology · 3
Efficacy of Pulsed Low-Dose-Rate Reirradiation: Results From a Phase 1 Clinical Trial
2016 · J.E. Meyer, T.J. Galloway, et al. · International Journal of Radiation Oncology*Biology*Physics · 2
PDF
Phase I Study of Pulsed Low Dose-Rate Reirradiation: A Dose-Escalation Study to Establish Maximum Tolerated Dose
2015 · J.E. Meyer, T.J. Galloway, et al. · International Journal of Radiation Oncology*Biology*Physics
PDF
Preliminary Results of a Phase 1 Study of Hyperfractionated Low-Dose Radiation Therapy (RT) as a Chemotherapy Sensitizer in Combination With Gemcitabine (G) and Erlotinib (E) in Advanced Pancreatic Cancer
2013 · A.A. Konski, J. Meyer, et al. · International Journal of Radiation Oncology*Biology*Physics
PDF
A phase I study of hyperfractionated low-dose radiotherapy (RT) as a chemotherapy sensitizer in combination with gemcitabine (G) and erlobtinib (E) in advanced pancreatic cancer.
2013 · Andre A. Konski, Joshua E. Meyer, et al. · Journal of Clinical Oncology
Works count: 8
Citation count: 48
H-index: 3
I10-index: 2
Year
Topic
Type